Investing Profile

Sara Nayeem

VCInvestor
Partner at Avoro Ventures
avorocapital.com/team/Washington, District of Columbia
Photo of Sara Nayeem, Partner at Avoro Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Harvard University Network
402 CONNECTIONS
Yale University Network
182 CONNECTIONS
New Enterprise Associates (NEA) Network
57 CONNECTIONS
New Enterprise Associates (NEA) Network
57 CONNECTIONS
New Enterprise Associates (NEA) Network
57 CONNECTIONS
cb
$100K - $10.0M
$1M
13
CompanyStageDateRound SizeTotal Raised
Normunity
Series BJan 2025$75M
$140M
Co-investors: Tim Shannon (Canaan Partners), Paulina Hill (Polaris Partners)
Aviceda Therapeutics
Series CJan 2025$210M
$210M
Vanqua Bio
Series BSep 2021$85M
$85M
Co-investors: Jonathan Silverstein (OrbiMed)
Centrexion Therapeutics
Series DJan 2018$67M
$67M
Complexa
Series CJul 2017$62M
$62M
Co-investors: Barbara Dalton (Pfizer Venture Investments), David Mott (Mott Family Capital)
Mersana Therapeutics
Series CJun 2016$33M
Series BMar 2015$35M
Series AApr 2014$15M
Series AJul 2012$27M
$110M
Co-investors: David Parkinson (ESSA Pharma), Elliott Sigal
TESARO
Post Ipo EquityFeb 2016$160M
Series BJun 2011$100M
Series AMay 2010$60M
$320M
Co-investors: Nina Kjellson (Canaan Partners), David Mott (Mott Family Capital), Beth Seidenberg (Kleiner Perkins)
Therachon
Series ASep 2015$35M
$100M
Co-investors: Tom Woiwode (Versant Ventures)
Partner New Enterprise Associates (NEA)2015 - 2021
Principal New Enterprise Associates2010 - 2015
Principal New Enterprise Associates (NEA)2010 - 2015
Senior Associate New Enterprise Associates2009 - 2009
Senior Associate New Enterprise Associates (NEA)2009 - 2009
Yale University MD / MBA
Harvard University AB Biological Sciences